KK
NPCE icon

Kotler Kevin’s Neuropace NPCE Stock Holding History

Kotler Kevin’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$9.75M Buy
+631,468
New +$8.44M 2.28% 8

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Kotler Kevin's NPCE Position: Q4 2025 in Review

Kotler Kevin opened a new position in Neuropace (NPCE) in Q4 2025: 631,468 shares worth $9.75M. The stake represents 2.28% of the portfolio and ranks #8 among its holdings.

100 funds tracked by Wall St. Rank hold NPCE as of Q4 2025.

  • Kotler Kevin held 631,468 shares of Neuropace worth $9.75M as of Q4 2025.
  • Neuropace was a new Kotler Kevin position in Q4 2025.
  • Neuropace made up 2.28% of Kotler Kevin's portfolio in Q4 2025, its #8 holding.
  • 100 funds tracked by Wall St. Rank held Neuropace as of Q4 2025.

Based on Kotler Kevin's 13F filing for Q4 2025, filed 17 Feb 2026.